Ion Beam Applications SA IBAB
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- €15.42
- Day Range
- €15.16–15.42
- 52-Week Range
- €9.90–17.76
- Bid/Ask
- €15.10 / €15.50
- Shares Outstanding
- 29.04M
- Market Cap
- €440.25M
- Volume/Avg
- 14,670 / 21,210
Key Statistics
- Price/Earnings (Normalized)
- 16.06
- Price/Sales
- 0.74
- Dividend Yield (Trailing)
- 1.62%
- Dividend Yield (Forward)
- 1.62%
- Dividend Payment Schedule
- Jul
- Total Yield
- 2.16%
Company Profile
Ion Beam Applications SA develops and manufactures medical devices and software solutions. The firm operates in three segments: IBA Clinical, including Proton Therapy and Dosimetry; IBA Technologies; and IBA Corporate. Proton therapy and other accelerators contribute to the majority of sales. It offers solutions for precision cancer treatment through the use of proton beams, as well as cyclotrons used for the production of radioisotopes and industrial accelerators for sterilization and ionization. The dosimetry business sells measurement and quality assurance instruments for radiotherapy and medical imaging. The firm operates in three geographical areas: Belgium, the United States, China, Germany, and India.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 2,300
- Website
- https://www.iba-worldwide.com
Valuation
|
Metric
|
IBAB
|
|---|---|
Price/Earnings (Normalized) | 16.06 |
Price/Book Value | 4.56 |
Price/Sales | 0.74 |
Price/Cash Flow | 11.83 |
Price/Earnings
IBAB
Financial Strength
|
Metric
|
IBAB
|
|---|---|
Quick Ratio | 0.58 |
Current Ratio | 0.99 |
Interest Coverage | 7.54 |
Quick Ratio
IBAB
Profitability
|
Metric
|
IBAB
|
|---|---|
Return on Assets (Normalized) | 3.25% |
Return on Equity (Normalized) | 22.10% |
Return on Invested Capital (Normalized) | 10.08% |
Return on Assets
IBAB
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|J&&Wl< | LOCK|Z&?l# | $167B | |||
| Medtronic PLC
MDT
| LOCK|C$g?N<W | LOCK|#<^# | $111B | |||
| Stryker Corp
SYK
| LOCK|!yjLGZ?k | LOCK|Ns | $105B | |||
| Boston Scientific Corp
BSX
| LOCK|C@skC<w | LOCK|hZWJ | $63B | |||
| Edwards Lifesciences Corp
EW
| LOCK|RSRQ#CR | LOCK|JB$lf | $49B | |||
| DexCom Inc
DXCM
| LOCK|>l#thST | LOCK|?!!YV | $33B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|fZdM^#j | LOCK|gf | $29B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|?G! | LOCK|^> | $23B | |||
| Steris PLC
STE
| LOCK|G>X?#c | LOCK|JkDy< | $20B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|lg^!Lzf< | LOCK|Bt? | $17B |
United States